Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+27.3%
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+27.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202431.09%
2023-2.44%
2022-38.47%
202115.06%
202012.39%
2019-142.97%
2018-188.12%
20170.00%